rs11214218 - schizophrenia risk SNP
Upload your raw genetic data once, we'll show you which variants you carry and what the research says.
Key takeaways
- This SNP is linked to schizophrenia risk with a small effect size
- It increases expression of the gene in nerve tissue and colon tissue
- The association was found in a large GWAS study
Key takeaways
- This SNP is linked to schizophrenia risk with a small effect size.
- It increases expression of the gene in nerve tissue and colon tissue.
- The association was found in a large GWAS study.
What the research says The GWAS Catalog reports that the G allele of rs11214218 is associated with schizophrenia risk, with an effect size of 0.96 and a p-value of 6e-8 in about 175 thousand individuals [PMID 35396580]. GTEx data shows that the LINC02762 gene expression increases in nerve tissue and colon tissue [GTEx Portal].
Reported associations Schizophrenia: the G allele is associated with higher risk, effect size 0.96 p=6e-8 [PMID 35396580].
Evidence quality The GWAS used about 175 thousand individuals, yielding a small effect size of 0.96 and a highly significant p-value of 6e-8 [PMID 35396580]. No other studies are cited for this variant.
Tissue-specific expression effects
- LINC02762: increased expression in nerve tissue and colon tissue [GTEx Portal].
Last lifestyle considerations on file for this variant.
Frequently asked questions
What does rs11214218 mean?
It is a genetic variant linked to schizophrenia risk and shows higher expression in nerve tissue.
Is this gene related to cancer?
The data do not link this SNP to cancer.
Can I change my risk with lifestyle?
There are no lifestyle recommendations for this variant.